28-Nov-2022 - Bundesanstalt für Materialforschung und -prüfung (BAM)

Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral pharmaceutical production.

The consequences of global pharmaceutical production for the environment are serious: the manufacture of active pharmaceutical ingredients consumes large amounts of energy due to multi-stage work processes and is associated with a corresponding high CO2 footprint. Unused reaction products enter the soil via wastewater and pollute the environment. In particular, the intensive use of solvents, which are widely used in the pharmaceutical industry during the synthesis, burdens the eco-balance.

Yet a more sustainable and at the same time highly efficient and economical alternative to conventional pharmaceutical production already exists today: mechanochemistry. It uses mechanical processes, such as ball milling or resonance mixing, to set chemical reactions in motion. Here, the supply of thermal energy and the use of solvents can be largely dispensed with, because chemical and physical transformations are triggered here with mechanical force.

“In principle, the process has been known for centuries and has been used for several years by scientists for the synthesis of different materials," explains Franziska Emmerling, BAM expert for mechanochemical processes. "The technology developed in laboratories must now make the leap into industry, and chemists all over the world are working on this. So far, however, a lack of understanding of the exact mechanistic processes has hindered a broad application of the method. This is mainly because the reactions are very difficult to observe and systematise. Thus, the full potential of mechanochemistry remains untapped."

In the new joint project IMPACTIVE (Innovative Mechanochemical Processes to synthesise green active pharmaceutical ingredients), in which Franziska Emmerling is conducting research together with colleagues from seven European countries, this is precisely what is to be changed. In IMPACTIVE, six active pharmaceutical ingredients are being produced on a pilot scale for the first time without any solvents at all. The agents come from the fields of cancer medicine, antidiabetics and antihypertensives.

"At BAM we have developed so-called time-resolved methods with which the reactions can be precisely observed and described," says Emmerling's colleague Lucia Casali. "In a benchmarking exercise, we then want to show the advantages of mechanochemistry over conventional processes in the pharmaceutical sector.”

The potential is large: a recent Israeli study has shown that switching pharmaceutical production to mechanochemistry could reduce the industry's ecotoxicity and CO2 emissions by more than 85% - with a significant reduction in manufacturing costs.

In addition to BAM, eight other renowned European institutions are involved in IMPACTIVE, which is funded by the EU's Horizon 2020 funding programme, including the universities of Montpellier, Nijmegen and Louvain, Trinity College in Dublin and the Israeli Institute of Technology.

Facts, background information, dossiers

More about BAM

  • News

    A novel path for sustainable photon upconversion with non-precious metals

    Sustainable chemical applications need to be able to employ renewable energy sources, renewable raw materials, and earth-abundant elements. However, to date many techniques have only been possible with the use of expensive precious metals or rare earth metals, the extraction of which can ha ... more

    How good is the measurement method?

    The causes of accidents can be diverse, whether it is an explosion in a chemical plant or a fire on a dangerous goods freighter. Prevention starts in the laboratory where chemicals are tested for their hazardous properties. Safety experts, haulage contractors or traders must be able to rely ... more

  • q&more articles

    On the way to the cyber-physical lab

    Laboratories tend to be central hubs for chemical, biotechnological, pharmaceutical or foodstuff production. They play a key role in research and development, chemical analysis, quality assurance, maintenance and process control. more

    The internet of things in the lab and in process

    It is a fact that much of the time spent on analytical laboratory instrumentation these days goes into system maintenance. Digital transformation could give us more time again for creativity and our actual laboratory work – if we shape it the right way. more

    The fingerprint of the diatom

    In today’s laboratories, elemental analysis methods are used for more than just determining total metal content in various sample matrices. They have become an important tool for life science research in environmental science, medicine and biology. more

  • Authors

    Dr. Michael Maiwald

    Michael Maiwald, born in 1967, is head of the division Process Analytical Technology at Bundesanstalt für Materialforschung und -prüfung (BAM) in Berlin, Germany. He is physico-chemist who in 1994 graduated from Ruhr-University Bochum, Germany, where he also received his doctorate. Subseque ... more

    Dr. Björn Meermann

    Björn Meermann, born in 1982, studied chemistry at the University of Münster and obtained his doctorate in 2009 in the working group of Prof. Dr. Uwe Karst. This was followed by a postdoctoral period of almost two years at the University of Ghent (Belgium) in the working group of Prof. Dr. ... more

    Dr. Martina Hedrich

    Martina Hedrich studied chemistry at Freie Universität Berlin (FUB), where she also received her doctorate in inorganic chemistry in the field of X-ray structure analysis. During her postdoc at the Hahn Meitner Institute in Berlin, she dedicated her work to trace analysis in human tissue sa ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: